BioCryst Pharmaceuticals | BCRX - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals reported $-28415000 in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
Alnylam Pharmaceuticals ALNY:US USD -149807000 38.81M
BioCryst Pharmaceuticals BCRX:US USD -28415000 17.9M
Chugai Pharma 4519:JP JPY 98.3B 51.18B
Daiichi Sankyo 4568:JP JPY -6551000000 38.1B
Enanta Pharmaceuticals ENTA:US USD -39451000 9.44M
Gilead Sciences GILD:US USD 1.7B 562M
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Glaxosmithkline GSK:US GBP 2.08B 215M
Incyte Corp INCY:US USD 24.77M 45.32M
Intra Cellular Therapies ITCI:US USD -48392000 980K
Ionis Pharmaceuticals IONS:US USD -114148000 93.87M
Karyopharm Therapeutics KPTI:US USD -30899000 2.97M
Mirati Therapeutics MRTX:US USD -193823000 17.9M
Neurocrine Biosciences NBIX:US USD -114200000 217.6M
Novavax NVAX:US USD -312768000 68.89M
PTC Therapeutics PTCT:US USD -117615000 82.73M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Roche Holding ROG:VX CHF 5.93B 5.62B
Sarepta Therapeutics SRPT:US USD -525417000 416.01M
Ultragenyx Pharmaceutical RARE:US USD -154105000 8.48M
Vertex Pharmaceuticals VRTX:US USD 779M 254.5M